Cochrane · intervention · CD006968
Local interventions for the management of alveolar osteitis (dry socket)
Daly, BJM, Sharif, MO, Jones, K, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library
Full textEvery question was extracted from the full review (methods and results), not only its Summary of Findings table.
Questions
52
current version
GRADE rated
5
No studies
3
Included studies
49
as reported
No studies 3 · 5.8%Ungraded 44 · 84.6%Very low 2 · 3.8%Low 1 · 1.9%Moderate 2 · 3.8%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Review question
| Element | Planned (methods) | Found (results) |
|---|---|---|
| Population | Adults over 18 years who had undergone an extraction (routine or more complex surgical) of one or more permanent teeth under local anaesthesia (with or without sedation) or general anaesthesia, or who had developed dry socket post-extraction; smokers included; immunocompromised participants or those with comorbidities/medical conditions affecting oral healing excluded | 6771 participants across 49 trials; 39 prevention trials (6219 participants) and 10 treatment trials (552 participants); all but five studies involved extraction of third molars |
| Intervention | Any type of local intervention used for the prevention or treatment of dry socket (antiseptic rinses, intrasocket gels/medicaments, tissue patches, autologous platelet concentrates, obtundent dressings); concomitant pain medication allowed if equal between groups; systemic antibiotics and surgical techniques excluded (covered by separate reviews) | Chlorhexidine rinse 0.12%/0.2% (n=6); Chlorhexidine gel 0.2% (n=7); Chlorhexidine gel vs rinse (n=2); Platelet rich plasma (n=2); Honey (n=1); Gaseous ozone (n=1); Chlorhexidine monoject irrigation (n=1); Herbal mouthrinse (n=1); Tap water irrigation (n=1); Povidone iodine 1% (n=1); Oral tissue patch (n=1); Chlorhexidine gel 1% vs 0.2% (n=1); Acellular dermal matrix (n=2); Iodine tampon (n=1); Platelet rich fibrin (n=1); Bovine fibroblast growth factor (n=1); Metronidazole gel (n=1); Apernyl (n=1); Tranexamic acid (n=1); P-hydroxybenzoic acid (n=1); Heal-all tissue patch (n=1); Artemisia desertorum spreng Shahaosan/Yunnan (n=1); Zinc oxide eugenol/Alvogyl (n=2); Neocone (n=1); Topical anaesthetic gel (n=1); Plasma rich in growth factors PRGF (n=1); Advanced platelet rich fibrin (n=1); Metronidazole (n=1); Alvogyl vs SaliCept/no treatment (n=1); Alvogyl vs platelet rich fibrin (n=1) |
| Comparison | A different local intervention; placebo; or no treatment | Placebo/no treatment; Chlorhexidine rinse; Chlorhexidine gel; Saline; Eugenol; Alvogyl; Zinc oxide eugenol; Control |
| Outcomes | Prevention primary: proportion of participants presenting with a dry socket within 1 week post-treatment. Treatment primary: time to heal dry socket and socket healing indices; pain (severity and duration); swelling; limitation of chewing or swallowing; fever. Secondary: quality of life; patient satisfaction; costs. Adverse effects reported in a table | Presence of dry socket (n=39 prevention); Pain VAS (treatment; n=5+); Time to initial pain relief and complete resolution of pain (n=1); Duration of treatment (n=1); Healing (n=2); Exposed bone (n=1); Adverse events (tabulated) |
| Study designs | Randomised controlled trials only (split-mouth/cross-over designs allowed for prevention) | RCT (n=49) |
| Timing | Clinically important time points: at the end of the intervention and during follow-up of up to 2 weeks | Prevention median 7 days follow-up; treatment pain assessed at 48 hours to day 7 |
Search date: 2021-09. Databases: Cochrane Oral Health's Trials Register; Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE Ovid; Embase Ovid; ClinicalTrials.gov; trial registries
Questions and results
Show all 3 versionsChlorhexidine rinse (0.12% and 0.2%, pre- and post-extraction) vs Placebo or no treatment
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Adverse events Follow-up: median 7 days | 3 trials reported no adverse events. 1 study reported adverse events (alterations in taste, bad taste, staining) in 24/62 in chlorhexidine group versus 0/40 in placebo group, Peto OR = 8.42 (95% CI 3.31 to 21.39). A… | 6 studies | Ungraded |
Presence of dry socket Follow-up: median 7 days | OR 0.38 [0.25, 0.58] 300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 140 per 1000 | 6 studies · 1547 participants | Moderate Downgraded: risk of bias |
Chlorhexidine gel (0.2%, intrasocket) vs Placebo or no treatment
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Adverse events Follow-up: median 7 days | No adverse events were reported. Six trials (673 participants) reported no adverse events from the use of chlorhexidine gel; one study (Rubio-Palau 2015) reported gastrointestinal discomfort (30, 18%), dizziness (10,… | 7 studies | Ungraded |
Presence of dry socket Follow-up: median 7 days | OR 0.44 [0.27, 0.71] 300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 159 per 1000 | 7 studies · 753 participants | Moderate Downgraded: risk of bias |
Chlorhexidine gel (0.2%, intrasocket) vs Chlorhexidine rinse (0.12%)
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Adverse events Follow-up: median 7 days | No adverse events were reported in these two trials (Abu-Mostafa 2015; Hita-Iglesias 2008). | 2 studies | Ungraded |
Presence of dry socket Follow-up: median 7 days | RR 0.74 [0.46, 1.20] 300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 222 per 1000 | 2 studies · 383 participants | Low Downgraded: risk of bias, imprecision |
Chlorhexidine rinse (0.2%) pre- and post-extraction vs Chlorhexidine rinse (0.2%) post-extraction only
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.58 [0.15, 2.17] | 1 study · 99 participants | Ungraded |
Acellular dermal matrix vs Control
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.15 [0.04, 0.67] | 1 study · 300 participants | Ungraded |
Presence of dry socket Follow-up: median 7 days | RR 0.07 [0.01, 0.50] | 1 study · 400 participants | Ungraded |
Glucocorticosteroid antibiotic agent (intrasocket) vs Normal saline
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | OR (exact) 0 [0, 2.42] | 1 study · 19 participants | Ungraded |
Clindamycin phosphate antibiotic solution patch vs Saline patch
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | OR (exact) 0 [0, 0.69] | 1 study · 86 participants | Ungraded |
Metronidazole gel (25%, intrasocket) vs Placebo gel
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.53 [0.23, 1.20] | 1 study · 302 participants | Ungraded |
Apernyl (acetylsalicylic acid pellet) vs Placebo
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.25 [0.03, 2.16] | 1 study · 100 participants | Ungraded |
Platelet rich plasma vs Placebo or no treatment
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.51 [0.19, 1.33] 300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 153 per 1000 | 2 studies · 127 participants | Very low Downgraded: risk of bias, imprecision |
Adverse events Follow-up: median 7 days | No adverse events were reported in these two trials. | 2 studies | Ungraded |
Tranexamic acid (AMCA cones) vs Placebo (lactose cones)
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.67 [0.30, 1.48] | 1 study · 120 participants | Ungraded |
P-hydroxybenzoic acid vs Placebo
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.08 [0.00, 1.37] | 1 study · 45 participants | Ungraded |
Heal-all tissue patch vs No treatment
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.08 [0.00, 1.32] | 1 study · 80 participants | Ungraded |
Artemisia desertorum spreng (Shahaosan) vs Placebo
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.13 [0.02, 1.02] | 1 study · 188 participants | Ungraded |
Artemisia desertorum spreng (Yunnan) vs Placebo
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.28 [0.06, 1.28] | 1 study · 182 participants | Ungraded |
Artemisia desertorum spreng (Shahaosan) vs Artemisia desertorum spreng (Yunnan)
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.47 [0.04, 5.06] | 1 study · 178 participants | Ungraded |
Topical anaesthetic gel (prilocaine-lidocaine) vs Eugenol
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain at 48 hours (VAS 0-10) 48 hours | MD -0.20 [-1.87, 1.47] | 1 study · 35 participants | Ungraded |
Metronidazole (intrasocket) vs Placebo
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Duration of treatment (days) | MD -3.17 [-5.30, -1.04] | 1 study · 55 participants | Ungraded |
Alvogyl vs No treatment
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain (VAS) | Alvogyl versus No treatment (Kaya 2011): data not usable (medians presented with error bars). Text reports differences in clinical signs and symptoms between control and all 3 treatment groups significant (P<0.05) at… | 1 study | Ungraded |
SaliCept (acemannan hydrogel) vs No treatment
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain (VAS) | SaliCept (acemannan hydrogel) versus No treatment (Kaya 2011): data not usable (medians presented with error bars). Text reports differences in clinical signs and symptoms between control and all 3 treatment groups… | 1 study | Ungraded |
Alvogyl vs SaliCept (acemannan hydrogel)
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain (VAS) | Alvogyl versus SaliCept (acemannan hydrogel) (Kaya 2011): data not usable (medians presented with error bars). Text reports differences in clinical signs and symptoms between control and all 3 treatment groups… | 1 study | Ungraded |
Honey (Manuka, topical) vs Chlorhexidine rinse (0.2%)
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 1.32 [0.41, 4.22] | 1 study · 100 participants | Ungraded |
Gaseous ozone vs Placebo or control
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.20 [0.02, 1.61] | 1 study · 60 participants | Ungraded |
Chlorhexidine 0.2% socket irrigation (monoject syringe) vs Chlorhexidine 0.2% mouthrinse
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.26 [0.09, 0.71] | 1 study · 95 participants | Ungraded |
Herbal mouthrinse vs Chlorhexidine 0.2% mouthrinse
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.50 [0.05, 5.17] | 1 study · 50 participants | Ungraded |
Tap water irrigation (monoject syringe) vs No rinsing
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.36 [0.18, 0.74] | 1 study · 336 participants | Ungraded |
Povidone iodine 1% vs Control
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.36 [0.14, 0.98] | 1 study · 189 participants | Ungraded |
Oral tissue patch vs Placebo or control
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.13 [0.02, 0.98] | 1 study · 200 participants | Ungraded |
Chlorhexidine gel 1% vs Chlorhexidine gel 0.2%
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.55 [0.15, 2.05] | 1 study · 88 participants | Ungraded |
Iodine tampon vs Saline irrigation (monoject syringe)
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | Iodine tampon versus rinsing with saline in a syringe (Tuk 2019): Iodine tampon 0/54 Monoject with saline 0/54; no events (effect not estimable) | 1 study · 108 participants | Ungraded |
Platelet rich fibrin vs Control
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.44 [0.15, 1.35] | 1 study · 100 participants | Ungraded |
Recombinant bovine fibroblast growth factor gel vs Control
Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Presence of dry socket Follow-up: median 7 days | RR 0.10 [0.01, 0.76] | 1 study · 160 participants | Ungraded |
Zinc oxide eugenol vs Alvogyl (old formulation)
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Swelling | No studies reported this outcome | 0 studies | No studies |
Limitation of chewing or swallowing | No studies reported this outcome | 0 studies | No studies |
Healing | Healing: 2 studies (Faizel 2015; Supe 2018) used different healing outcomes and could not be combined; Alvogyl appeared to heal faster than zinc oxide eugenol. Supe 2018: delayed (non-healed after 10 days) 2/25 Alvogyl… | 2 studies | Ungraded |
Pain (VAS 0-10) Day 7 | MD 1.40 [1.04, 1.75] Alvogyl: median 1.7 (VAS 0-10) vs Zinc oxide eugenol: 1.04 higher to 1.75 higher | 2 studies · 80 participants | Very low Downgraded: risk of bias, inconsistency |
Fever | No studies reported this outcome | 0 studies | No studies |
Neocone vs Alvogyl
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Time to initial pain relief (minutes) Initial pain relief | MD 9.87 [9.12, 10.63] | 1 study · 78 participants | Ungraded |
Time to complete resolution of pain (days) Complete resolution of pain | MD -1.62 [-1.86, -1.38] | 1 study · 78 participants | Ungraded |
Neocone vs Zinc oxide eugenol
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Time to complete resolution of pain (days) Complete resolution of pain | MD -3.79 [-4.04, -3.54] | 1 study · 78 participants | Ungraded |
Time to initial pain relief (minutes) Initial pain relief | MD -7.77 [-8.86, -6.68] | 1 study · 78 participants | Ungraded |
Alvogyl vs Zinc oxide eugenol
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Time to complete resolution of pain (days) Complete resolution of pain | MD -2.17 [-2.37, -1.97] | 1 study · 78 participants | Ungraded |
Time to initial pain relief (minutes) Initial pain relief | MD -17.64 [-18.76, -16.52] | 1 study · 78 participants | Ungraded |
Plasma rich in growth factors (PRGF) vs Alvogyl
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Exposed bone (present versus absent) Day 7 (also day 3) | PRGF versus Alvogyl (King 2018), exposed bone (% patients): day 3 PRGF 9.1% vs Alvogyl 9.1%; day 7 PRGF 0% vs Alvogyl 22.7% (P<0.05 at day 7) Alvogyl: 22.7% (day 7); 9.1% (day 3) vs PRGF: 0% (day 7); 9.1% (day 3) | 1 study · 44 participants | Ungraded |
Pain (VAS cm) Day 7 (also day 3) | MD -0.40 [-1.77, 0.97] | 1 study · 44 participants | Ungraded |
Advanced platelet rich fibrin (A-PRF) vs Control (no treatment)
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain (VAS cm) Days 1-7 (day 7 shown) | MD -3.60 [-4.00, -3.20] | 1 study · 40 participants | Ungraded |
Alvogyl vs Platelet rich fibrin
Population: Adults (>18 years) with established dry socket following permanent tooth extraction
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain | Alvogyl versus platelet rich fibrin (Keshini 2020): single study (30 participants); no usable pooled estimate extracted | 1 study · 30 participants | Ungraded |